Charles River Labs (RV6) Financial Statements
Charles River Labs Financial Overview
Charles River Labs's market cap is currently $14.15B. The company's EPS TTM is $-4.84; its P/E ratio is -74.26; Charles River Labs is estimated to report earnings on November 4, 2026, and the estimated EPS forecast is $2.44. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.02B | $ 4.05B | $ 4.13B | $ 3.98B | $ 3.54B |
| Gross Profit | $ 1.23B | $ 1.33B | $ 1.50B | $ 1.46B | $ 1.33B |
| Operating Income | $ 507.84M | $ 227.35M | $ 617.26M | $ 650.98M | $ 589.86M |
| EBITDA | $ 410.84M | $ 581.14M | $ 1.03B | $ 986.15M | $ 820.16M |
| Net Income | $ -144.34M | $ 10.30M | $ 474.62M | $ 486.23M | $ 390.98M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 213.77M | $ 194.61M | $ 276.77M | $ 233.91M | $ 246.30M |
| Total Assets | $ 7.14B | $ 7.53B | $ 8.20B | $ 7.60B | $ 7.02B |
| Total Debt | $ 3.07B | $ 2.72B | $ 3.07B | $ 3.10B | $ 3.21B |
| Net Debt | $ 2.85B | $ 2.53B | $ 2.79B | $ 2.86B | $ 2.96B |
| Total Liabilities | $ 3.92B | $ 4.02B | $ 4.54B | $ 4.58B | $ 4.43B |
| Stockholders' Equity | $ 3.16B | $ 3.46B | $ 3.60B | $ 2.98B | $ 2.53B |
| Cash Flow | |||||
| Free Cash Flow | $ 518.49M | $ 501.61M | $ 365.37M | $ 294.91M | $ 532.03M |
| Operating Cash Flow | $ 737.65M | $ 734.58M | $ 683.90M | $ 619.64M | $ 760.80M |
| Investing Cash Flow | $ -209.32M | $ -245.09M | $ -563.15M | $ -607.92M | $ -1.44B |
| Financing Cash Flow | $ -536.73M | $ -550.93M | $ -85.52M | $ -42.40M | $ 672.60M |
Currency in USD
